Status:
RECRUITING
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Lead Sponsor:
Peking University First Hospital
Conditions:
Atopic Dermatitis Eczema
Prurigo Nodularis
Eligibility:
All Genders
Brief Summary
In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and t...
Eligibility Criteria
Inclusion
- Patients from the medical units that has passed the data review of the National Clinical Center for Skin and Immune Diseases (see the study sites for data collection for details);
- patients diagnosed with type 2 inflammatory skin diseases (dermatitis/eczema, urticaria, pemphigoid, prurigo nodularis).
Exclusion
- patients who fail to provide informed consent form;
- patients who cannot complete the questionnaire independently or under the guidance of investigators
Key Trial Info
Start Date :
August 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2031
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT05316805
Start Date
August 31 2021
End Date
December 31 2031
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, China